Merck & Co., Inc. (MRK)

122.43 6.56 (5.66%)

As of 2026-05-22 15:18:22 EST

Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fifth on the list of largest biomedical companies by revenue.

Traded asNYSE: MRK
ISINUS58933Y1055
CIK0000310158
LEI—
EIN221918501
SectorPharmaceuticals
IndustryPharmaceutical Preparations
CEORobert M. Davis
Employees75,000
Fiscal Year End1231
Address126 EAST LINCOLN AVENUE, RAHWAY, NJ, 07065
Phone908-740-4000
Websitehttp://merck.com
Stock Quotes
trading_symbolregistrant_nametimepricechangepercentage_change
MRKMerck & Co., Inc.2026-05-22 15:18:22122.436.565.66
This is a preview of the latest data. Subscribe to access the full data.
Company Information
trading_symbolcentral_index_keyregistrant_nameisin_numberlei_numberein_numberexchangesic_codesic_descriptionfiscal_year_endstate_of_incorporationaddress_streetaddress_cityaddress_stateaddress_zip_codeaddress_countryaddress_country_codephone_numbermailing_addressbusiness_addressformer_nameindustryfounding_datechief_executive_officernumber_of_employeeswebsitemarket_capshares_issuedshares_outstandingdescriptionupdate_time
MRK0000310158Merck & Co., Inc.US58933Y1055—221918501NYSE2834Pharmaceutical Preparations1231NJ126 EAST LINCOLN AVENUERAHWAYNJ07065UNITED STATESUS908-740-4000126 EAST LINCOLN AVENUE, RAHWAY, NJ, 07065126 EAST LINCOLN AVENUE, RAHWAY, NJ, 07065Merck & Co. Inc.Pharmaceuticals1891Robert M. Davis75,000http://merck.com198,051,000,0003,577,103,5222,469,824,415Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fifth on the list of largest biomedical companies by revenue.2026-05-21 15:06:45
This is a preview of the latest data. Subscribe to access the full data.
MRK Stock Price (End-of-Day)
This is a preview of the latest data. Subscribe to access the full data.
MRK Stock Price (1-Minute)
This is a preview of the latest data. Subscribe to access the full data.
Market Cap
Fiscal YearMarket CapChange In Market CapPercentage Change In Market CapShares OutstandingChange In Shares OutstandingPercentage Change In Shares Outstanding
2025198,051,000,000-115,748,000,000-36.8862,472,392,003-53,644,237-2.1237
2024313,799,000,00020,870,000,0007.12462,526,036,240-6,607,632-0.2609
2023292,929,000,00062,109,000,00026.9082,532,643,872-5,948,595-0.2343
This is a preview of the latest data. Subscribe to access the full data.
Executive Compensation
Executive NameExecutive PositionFiscal YearSalaryBonusStock AwardsIncentive Plan CompensationOther CompensationTotal Compensation
Sanat ChattopadhyayExecutive Vice President, President2025982,17002,363,261920,710191,1995,408,408
Dean LiExecutive Vice President, President20251,460,00004,296,8641,368,640168,5478,892,881
Robert M. DavisChairman, Chief Executive Officer, President20251,645,302012,102,8382,326,500658,05820,797,845
Caroline LitchfieldChief Financial Officer, Executive Vice President20251,173,21403,580,6811,099,800127,6187,514,085
Jennifer ZacharyGeneral Counsel, Executive Vice President20251,062,21702,685,571995,749112,7225,860,578
This is a preview of the latest data. Subscribe to access the full data.
Employee Count
Fiscal YearEmployee Count
202575,000
202475,000
202372,000
This is a preview of the latest data. Subscribe to access the full data.
Income Statements
Fiscal Year202520242023
Revenue65,011,000,00064,168,000,00060,115,000,000
Cost Of Revenue16,382,000,00015,193,000,00016,126,000,000
Gross Profit48,629,000,00048,975,000,00043,989,000,000
Research And Development Expenses15,789,000,00017,938,000,00030,531,000,000
General And Administrative Expenses10,733,000,00010,816,000,00010,504,000,000
Operating Expenses27,562,000,00029,039,000,00042,100,000,000
Operating Income21,067,000,00019,936,000,0001,889,000,000
Net Income18,254,000,00017,117,000,000365,000,000
Earnings Per Share Basic7.36.760.14
Earnings Per Share Diluted7.286.740.14
Weighted Average Shares Outstanding Basic2,502,000,0002,532,000,0002,537,000,000
Weighted Average Shares Outstanding Diluted2,507,000,0002,541,000,0002,547,000,000
This is a preview of the latest data. Subscribe to access the full data.
Balance Sheet Statements
Fiscal Year202520242023
Cash And Cash Equivalents14,565,000,00013,242,000,0006,841,000,000
Marketable Securities Current0447,000,000252,000,000
Accounts Receivable1,600,000,0002,100,000,0003,000,000,000
Inventories6,658,000,0006,109,000,0006,358,000,000
Non Trade Receivables———
Other Assets Current10,518,000,0008,706,000,0008,368,000,000
Total Assets Current43,516,000,00038,782,000,00032,168,000,000
Marketable Securities Non Current956,000,000463,000,000252,000,000
Property Plant And Equipment25,316,000,00023,779,000,00023,051,000,000
Other Assets Non Current18,818,000,00016,044,000,00011,996,000,000
Total Assets Non Current125,000,00078,324,000,00074,507,000,000
Total Assets136,866,000,000117,106,000,000106,675,000,000
Accounts Payable4,404,000,0004,079,000,0003,922,000,000
Deferred Revenue———
Short Term Debt2,589,000,0002,649,000,0001,372,000,000
Other Liabilities Current14,468,000,00015,694,000,00015,766,000,000
Total Liabilities Current28,327,000,00028,420,000,00025,694,000,000
Long Term Debt46,750,000,00034,462,000,00033,683,000,000
Other Liabilities Non Current7,688,000,0006,465,000,0008,792,000,000
Total Liabilities Non Current55,933,000,0000600,000,000
Total Liabilities84,260,000,000100,000,000250,000,000
Common Stock1,788,000,0001,788,000,0001,788,000,000
Retained Earnings73,075,000,00063,069,000,00053,895,000,000
Accumulated Other Comprehensive Income-4,287,000,000-4,945,000,000-5,161,000,000
Total Shareholders Equity52,606,000,00046,313,000,00037,581,000,000
This is a preview of the latest data. Subscribe to access the full data.
Cash Flow Statements
Fiscal Year202520242023
Depreciation And Amortization2,793,000,0002,395,000,0002,044,000,000
Share Based Compensation Expense820,000,000761,000,000645,000,000
Other Non Cash Income Expense-511,000,000-510,000,000-355,000,000
Change In Accounts Receivable1,090,000,000244,000,0001,148,000,000
Change In Inventories1,180,000,000835,000,000816,000,000
Change In Non Trade Receivables———
Change In Other Assets———
Change In Accounts Payable110,000,000182,000,000-380,000,000
Change In Other Liabilities195,000,000-49,000,000456,000,000
Cash From Operating Activities16,472,000,00021,468,000,00013,006,000,000
Purchases Of Marketable Securities1,207,000,000519,000,000955,000,000
Sales Of Marketable Securities1,678,000,000377,000,0001,658,000,000
Acquisition Of Property Plant And Equipment4,112,000,0003,372,000,0003,863,000,000
Acquisition Of Business10,042,000,000746,000,0000
Other Investing Activities58,000,000127,000,00036,000,000
Cash From Investing Activities-13,741,000,000-7,734,000,0000
Tax Withholding For Share Based Compensation———
Payments Of Dividends8,248,000,0007,943,000,0007,551,000,000
Issuance Of Common Stock———
Repurchase Of Common Stock5,084,000,0001,306,000,0001,346,000,000
Issuance Of Long Term Debt13,880,000,0003,599,000,0005,939,000,000
Repayment Of Long Term Debt2,503,000,0001,290,000,0001,755,000,000
Other Financing Activities-131,000,000-372,000,000-328,000,000
Cash From Financing Activities-1,922,000,000-7,032,000,000-4,810,000,000
Change In Cash1,372,000,0006,409,000,000-5,864,000,000
Cash At End Of Period14,565,000,00013,242,000,0006,841,000,000
Income Taxes Paid6,086,000,0003,928,000,0004,338,000,000
Interest Paid1,300,000,0001,300,000,0001,100,000,000
This is a preview of the latest data. Subscribe to access the full data.
Key Metrics
Fiscal Year202520242023
Earnings Per Share7.36.760.14
Price To Earnings Ratio14.419214.716778.7143
Earnings Growth Rate7.98824,728.5714-97.5567
Price Earnings To Growth Ratio1.80510.0031-7.9822
Book Value Per Share21.025646.210941.9492
Price To Book Ratio5.00632.15272.5989
Ebitda28,490,000,00024,711,000,0007,893,000,000
Enterprise Value298,134,520,000275,752,360,000304,797,740,000
Dividend Yield0.03130.03150.0273
Dividend Payout Ratio0.45180.46420.6877
Debt To Equity Ratio0.93790.80130.9328
Capital Expenditures4,330,000,0003,123,000,0003,673,000,000
Free Cash Flow12,142,000,00018,345,000,0009,333,000,000
Return On Equity0.3470.36960.0097
One Year Beta0.38240.22070.2542
Three Year Beta0.31020.26030.2723
Five Year Beta0.29220.48220.5147
This is a preview of the latest data. Subscribe to access the full data.
Insider Transactions
Insider NameRelationship To IssuerTransaction DateAmount Of SecuritiesAcquired Or DisposedSecurities Owned Following Transaction
Guindo ChirfiEVP, Access, Policy & Comms2026-05-056,628A6,628
Guindo ChirfiEVP, Access, Policy & Comms2026-05-0519,402A19,402
Smart Dalton E. IIISVP Fin. - Global Controller2026-05-052,298A2,298
Smart Dalton E. IIISVP Fin. - Global Controller2026-05-055,045A5,045
Oosthuizen Johannes JacobusEVP, Oncology & Int?l2026-05-0510,605A10,605
This is a preview of the latest data. Subscribe to access the full data.
Senate Trading
Name Of Reporting PersonType Of Reporting PersonReport DateTransaction TypeTransaction DateOwner TypeAmount
Thomas H TubervilleSenator2023-11-16Sale (Full)2023-10-16Joint$1,001 - $15,000
John P RickettsSenator2023-10-20Sale (Full)2023-09-21Spouse$50,001 - $100,000
Thomas H TubervilleSenator2022-04-08Purchase2022-03-30Joint$1,001 - $15,000
Thomas H TubervilleSenator2021-07-23Sale (Full)2021-03-29Joint$1,001 - $15,000
David A Perdue , JrSenator2021-05-02Sale (Full)2020-04-14Joint$15,001 - $50,000
This is a preview of the latest data. Subscribe to access the full data.
House Trading
Name Of Reporting PersonReport DateStateTransaction TypeTransaction DateOwner TypeAmount
Josh Gottheimer2026-03-16NJ05Purchase2026-02-04Joint$1,001 - $15,000
Julie Johnson2026-01-15TX32Sale2025-12-18Joint$1,001 - $15,000
Gilbert Cisneros2026-01-12CA31Purchase2025-12-19—$1,001 - $15,000
Gilbert Cisneros2025-12-15CA31Purchase2025-11-18—$1,001 - $15,000
Julie Johnson2025-12-11TX32Sale (Partial)2025-11-13Joint$1,001 - $15,000
This is a preview of the latest data. Subscribe to access the full data.
Institutional Holdings
Investor NamePeriod Of ReportMarket ValueAmount Of SecuritiesPrice Per Security
ARGENT CAPITAL MANAGEMENT LLC2026-03-3122,308,141185,453120.29
COMPASS CAPITAL MANAGEMENT, INC2026-03-3170,943,192589,768120.29
Groupe la Francaise2026-03-318,840,17973,551120.1911
Raab & Moskowitz Asset Management LLC2026-03-316,341,48552,718120.2907
VESTOR CAPITAL, LLC2026-03-3126,603,000221,158120.2896
This is a preview of the latest data. Subscribe to access the full data.
Mutual Fund Holdings
Registrant NamePeriod Of ReportFund NameFund SymbolAmount Of UnitsValue In UsdPercentage Value Compared To Assets
BUFFALO FUNDS2026-03-31Institutional ClassBUIIX53,5006,797,409.740.8519
BUFFALO FUNDS2026-03-31Investor ClassBUFIX53,5006,797,409.740.8519
BUFFALO FUNDS2026-03-31Institutional ClassBUIDX9,8001,178,8420.707
BUFFALO FUNDS2026-03-31Investor ClassBUFDX9,8001,178,8420.707
BUFFALO FUNDS2026-03-31Institutional ClassBUIBX80,0009,623,2002.0731
This is a preview of the latest data. Subscribe to access the full data.